Participate in a T1D Clinical Trial

Choosing to participate in a T1D clinical trial is a very personal decision, but one that can have a significant impact on curing, preventing, and treating T1D. Explore additional clinical trial resources from Breakthrough T1D and our partners at Beyond Type 1 to learn more about clinical trials and their phases.

Check out this video series to learn more about participating in a clinical trial and why this is an important step in driving research progress:

Clinical Trials and You  English and Spanish

What Are Clinical Trials? English and Spanish

There are many opportunities in Maryland, Virginia, and Washington, DC to participate in a T1D clinical trial close to home. See below for active opportunities. You can also utilize Breakthrough T1D’s Clinical Trials Connection tool to find additional opportunities.

If you have any questions, please contact one of our Mid-Atlantic Chapter Clinical Trials Education Volunteers Tom Brobson or Sidney Smith.

FEATURED T1D STUDIES IN MID-ATLANTIC REGION

Study Name: Improving Transition Care for Adolescents and Young Adults With Type 1 Diabetes (SHIFT2)
The study is testing how health coaches can help teenagers transition from pediatric to adult diabetes care. One group of families will meet monthly virtually or in-person with a transition coach to discuss diabetes education and healthcare transition. Another group of families will receive monthly education about transitioning to adult care but will not work with a transition coach.

LOCATION: Children’s Hospital of Richmond at VCU, Richmond, VA

WHO CAN PARTICIPATE:

• Type 1 Diabetes diagnosis for at least 1 year
• 16-22 years old
• English speaking
• Must be a current patient of Children’s Hospital of Richmond at VCU
• Patient and caregiver must be willing to participate

CONTACT: Sarah Farthing, 804-527-4756 or sarah.malone@vcuhealth.org

 

UVA Center for Diabetes Technology Current Studies

 

TrialNet ATG Prevention Study (STOP-T1D) to delay or prevent T1D in people ages 12-35 who have a 50% risk of clinical diagnosis (Stage 3) within two years. (TrialNet STOP-T1D Study Flyer)

 

DIAGNODE-3 Study
The DIAGNODE-3 study is testing an investigational drug called Diamyd (rhGAD65) to see if it is able to preserve the body’s own insulin-producing capacity by halting or delaying the autoimmune attack on the beta cells.

PARTICIPANT AGE: 12 – 29 years old and diagnosed with T1D within the past six months.

LOCATION: Johns Hopkins, Baltimore, MD

CONTACT: Alexis Thomas, diagnode3study@jh.edu or 443-814-9385

ADULT

Algorithmic Development, Prototyping, And Pilot Clinical Testing of a Therapy Optimization Platform to Support Healthcare Providers in The Management of Type 2 Diabetes Preliminary Data Collection
UVA Health System Center for Diabetes Technology seeks adults between the ages of 18-80 who have type 2 diabetes to participate in a clinical research study. A study Dexcom G6 Continuous Glucose Monitor (CGM) will be provided to you to use during the study. The purpose of this study is to gather data that will be used to develop a future web-based application that will help doctors take better care of people living with type 2 diabetes. This study will ask for the collection of data that is generated as a part of your normal health care.

PARTICIPANT AGE: 18+

LOCATION: Charlottesville, VA

CONTACT: Jasmeen Dhillon, 434-466-7942 or jkd9ud@uvahealth.org

 

Adapting Diabetes Treatment Expert Systems to Patient’s Expectations and Psychobehavioral Characteristics in Type 1 Diabetes
UVA Center for Diabetes Technology seeks adults ages 18 and up with T1D for a research study to test different ways CGM data can be used to help manage diabetes. This study involves using a Dexcom G6 sensors, and an investigational diabetes application on an Android smart phone. Participants currently using multiple daily injections (MDI) may use a study insulin pump, if desired. There will be weekly surveys to complete, as well as 3 separate blood draws for A1c and lab values. This study will last approximately 7 months and there will be approximately 7 visits. All of these visits can be completed virtually using a web-based video conferencing tool. Study-related Dexcom G6 sensors, transmitters, and infusion sets if applicable will be provided free of charge.

PARTICIPANT AGE: 18+

LOCATION: Virtual or in-person in Charlottesville, VA

CONTACT: Emma Emory, EE9M@virginia.edu or 434-982-6479

 

A Safety, Tolerability, and Efficacy Study of VX-880 in Participants With Type 1 Diabetes
Read more about this clinical trial and its study site at VCU Medical Center in Richmond, VA here.

PEDIATRIC

Afrezza INHALE-1 Study in Pediatrics (INHALE-1)
This study aims to evaluate the safety and effectiveness of a rapid-acting inhaled insulin product for use in children and teenagers with diabetes.  Qualified participants will either take inhaled insulin for 12 months or continue mealtime injectable insulin for 6 months and then switch to inhaled insulin for the final 6 months. Read more.

PARTICIPANT AGE: 4-17 with type 1 or type 2 diabetes and using mealtime insulin (vial or pen, no pumps)

LOCATION: 39 study locations including Baltimore, MD, Richmond, VA and Wilmington, DE

CONTACT: Call 1-844-INHALE1 or visit https://go.afrezza.com/inhale1

 

Artificial Pancreas – Adolescent Physiology & Psychology Longitudinal Evaluation (AP APPLE)
UVA Center for Diabetes Technology is recruiting boys and girls who are 11 or 12 years old, going through puberty, and have been diagnosed with T1D for a 2-year research study. The study assesses changes in insulin resistance, glucose response, and psychosocial factors that are related to adolescent T1D management and glycemic control during their pubertal stages. The study requires four in-person visits and 15 phone or email check-in visits and there is $800 compensation for completion of the entire study.

PARTICIPANT AGE: 11 – 12

LOCATION: Charlottesville, VA and virtual

CONTACT: Lianna Smith at 434-284-0893 or lhs7px@uvahealth.org

 

Are you interested in participating in a clinical trial but these aren’t right for you? Check out Breakthrough T1D’s Clinical Trial Matching Tool, which can potentially match you with a clinical trial. You can also contact one of our Mid-Atlantic Chapter Clinical Trials Education Volunteers Tom Brobson or Sidney Smith.